CLINICAL TRIALS PROFILE FOR DIPROSONE
✉ Email this page to a colleague
All Clinical Trials for DIPROSONE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00910676 ↗ | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | Completed | Roche Pharma AG | Phase 2 | 2007-10-01 | Patients will receive local prophylactic treatment (Diprosone cream) during 8 weeks from the beginning of the EGF-R inhibitors treatment, on the areas of the body susceptible to be affected by folliculitis. |
| NCT00910676 ↗ | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | Completed | Centre Oscar Lambret | Phase 2 | 2007-10-01 | Patients will receive local prophylactic treatment (Diprosone cream) during 8 weeks from the beginning of the EGF-R inhibitors treatment, on the areas of the body susceptible to be affected by folliculitis. |
| NCT01466478 ↗ | An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris | Completed | LEO Pharma | Phase 1 | 2011-11-01 | The purpose of the study is to compare the 3 ointment formulations containing LEO 29102 plus calcipotriol and Daivonex® ointment and Diprosone® ointment and to compare LEO 29102 plus calcipotriol to LEO 29102 alone and to calcipotriol alone in the same ointment vehicle, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DIPROSONE
Condition Name
Clinical Trial Locations for DIPROSONE
Clinical Trial Progress for DIPROSONE
Clinical Trial Phase
Clinical Trial Sponsors for DIPROSONE
Sponsor Name
